Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Tyrosinase Monoclonal Antibody (T311)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA514177
Description
MA5-14177 targets Tyrosinase in ICC, IF, IHC (P), and WB applications and shows reactivity with Human samples. The MA5-14177 immunogen is recombinant tyrosinase protein.
The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene.
Specifications
Tyrosinase | |
Monoclonal | |
0.2 mg/mL | |
PBS with 0.05% BSA and 0.05% sodium azide; pH 7.4 | |
P11344, P14679 | |
TYR | |
Recombinant tyrosinase protein. | |
500 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG2a κ |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
T311 | |
Unconjugated | |
TYR | |
albino; albino locus protein; ATN; C; CMM8; LB24-AB; monophenol monooxygenase; Oca1; OCA1A; OCAIA; oculocutaneous albinism IA; SHEP3; SK29-AB; skc35; Tumor rejection antigen AB; TYR; Tyrosinase; tyrosinase (oculocutaneous albinism IA); tyrosinase precursor | |
Mouse | |
Protein A/G | |
RUO | |
22173, 7299 | |
4°C | |
Liquid |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction